Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam ED90 for Sedation in Orthopedic Surgery
NCT05340335Phase 4Completed
- Sponsor
- Asan Medical Center
- Start
- Apr 2022
- Primary completion
- May 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of remimazolam in sedation, sponsored by Asan Medical Center. Started Apr 2022; status: completed.
02
Drugs
remimazolam
03
Conditions
sedation
Beyond the preview
Go deeper on NCT05340335.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05340335.